Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28844254 | 0.92 | SLC2A1 (0.45) | SLC2A1CA2OPRM1CYP2D6 | |
| SCHEMBL27922219 | 0.92 | SLC2A1 (0.45) | SLC2A1CA2OPRM1CYP2D6 | |
| SCHEMBL6685769 | 0.82 | SLC2A1 (0.38) | SLC2A1CA2OPRM1CYP2D6 | |
| SCHEMBL29291684 | 0.76 | CYP17A1 (0.32) | CYP2D6 | |
| SCHEMBL28902632 | 0.76 | SLC2A1 (0.44) | SLC2A1CA2OPRM1CYP2D6 | |
| SCHEMBL11813334 | 0.74 | CYP2D6 (0.41) | SLC2A1CA2HSP90AA1CYP2D6ALDH1A1 | |
| SCHEMBL20273061 | 0.72 | NR1I2 (0.36) | SLC2A1 | |
| SCHEMBL22307857 | 0.72 | NR1I2 (0.36) | SLC2A1 | |
| SCHEMBL3526533 | 0.72 | HSP90AA1 (0.38) | HSP90AA1 | |
| SCHEMBL1301336 | 0.71 | NR1I2 (0.38) | OPRM1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1995012585-A1 | TEXTILE TREATMENT | UNIVERSITY OF LEEDS (GB) | 1995-05-11 | — | — | WO | claimed |
| US-20060252857-A1 | Aminoaryl-1-3-5-triazines and their use as uv absorbers | SCHAEFER THOMAS | 2006-11-09 | — | — | US | disclosed |
| CN-1795182-A | Aminoaryl-1, 3, 5-triazines and their use as UV absorbers | CIBA SC HOLDING AG (CH) | 2006-06-28 | — | — | CN | disclosed |
| EP-1641768-A2 | AMINOARYL-1-3-5 TRIAZINES AND THEIR USE AS UV ABSORBERS | Ciba SC Holding AG (CH) | 2006-04-05 | — | — | EP | disclosed |
| WO-2004106311-A2 | AMINOARYL-1-3-5 TRIAZINES AND THEIR USE AS UV ABSORBERS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-12-09 | — | — | WO | disclosed |
| WO-1995012585-A1 | TEXTILE TREATMENT | UNIVERSITY OF LEEDS (GB) | 1995-05-11 | — | — | WO | disclosed |
| WO-1995012585-A1 | TEXTILE TREATMENT | UNIVERSITY OF LEEDS (GB) | 1995-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060252857-A1 | Aminoaryl-1-3-5-triazines and their use as uv absorbers | IK, CRY2, CRY1 | SLC2A1 859/4885CA2 900/4885OPRM1 2515/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.